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Abstract 
Background: External ventricular drainage (EVD) is frequently used in different groups of 
patients in neurocritical care. Despite the frequent use of EVD, no consensus regarding the 
diagnosis of EVD related infection currently exists and diagnosis is commonly based on 
criteria for the diagnosis of non-EVD-related CNS infections. This study evaluates the 
diagnostic accuracy of clinical and laboratory parameters for the prediction of EVD-related 
infection in patients with proven EVD-related infection. 
Methods: In two tertiary care centers, data on EVD insertions were matched with 
microbiologic database of cultured microorganism and positive Gram stains of cerebrospinal 
fluid (CSF) to identify patients with EVD-related infections. Available clinical data and results 
of blood tests and CSF analysis were retrospectively collected. Predefined potential clinical 
and laboratory predictors of EVD-related infection were compared between three time 
points: at the time EVD insertion and 48 hours before and at the time of occurrence of EVD 
related infection.  
Results: 39 patients with EVD associated infection defined by positive CSF culture or positive 
CSF Gram stains and concomitant clinical signs of infection were identified. At the time of 
infection, a significantly higher incidence of abnormal temperature, high respiratory rate and 
a slightly but significantly higher incidence of decreased mental state were observed. The 
assessed blood and CSF parameters did not significantly differ between the different 
assessment time points. 
Conclusions: Our analysis of 39 patients with culture positive EVD-related infection showed 
that commonly used clinical and laboratory parameters are not reliable infection predictors.  
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Introduction 
External ventricular drainage (EVD) catheters are frequently used for the detection and 
management of elevated intracranial pressure (ICP). EVD allows accurate intracranial 
pressure monitoring and offers ICP control by temporarily draining cerebrospinal fluid (CSF). 
In neurocritical care, EVD is used in various disease states, but primarily in patients with 
subarachnoid (SAH) or intracerebral hemorrhage (ICH) or traumatic brain injury (TBI) [31].  
The incidences per 100’000 person-years range from 3-25 for SAH [7, 14, 16, 28], 16-33 for 
ICH [5, 21, 27] and 200 -530 for TBI [11, 26, 32]. A substantial proportion of these patients 
will require placement of an EVD catheter for appropriate treatment. Infection of the EVD 
catheter and subsequently of the intra- and periventricular space is one of the major 
complications of EVD placement [2]. The reported rates for EVD-related infections range 
from 2% to more than 27% in different studies [1, 2, 4, 6, 15, 30]. EVD-related infection has 
been related to higher morbidity and mortality and prolonged need of intensive care 
resources [19]. Despite the fact that optimal management of EVD-related infections is 
relevant for patient outcomes, no consensus on optimal prophylaxis, diagnosis and 
treatment exists [2, 34]. 
Diagnosis of EVD-related infection is commonly based on well-established criteria for the 
diagnosis of non-EVD-related CNS infections [33]. Rapidly available parameters for the 
diagnosis of central nervous system (CNS) infections include clinical signs such as fever, 
nuchal rigidity and a change in mental status as well as blood tests such as elevated white 
blood cell (WBC) count, neutrophilia with a shift towards immature band forms or elevated 
serum C - reactive protein (CRP) and procalcitonin (PCT) levels [3]. However, in neurocritical 
care patients clinical signs of central nervous system infection can be masked by the low 
level of consciousness due to the underlying condition or the treatment with sedative drugs. 
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Additionally, blood tests are non-specific, in that they may indicate infections of sites other 
than the CNS or be elevated due to causes not related to an infection. Analysis of CSF for 
EVD-related infection usually includes parameters determined by CSF WBC count. In patients 
suffering from SAH, ICH or TBI – the most frequent indications for EVD placement - CSF is 
frequently contaminated with blood and CSF-WBC based parameters may therefore be 
misleading. Additionally, the presence of blood in the CSF space can induce a sterile 
inflammation and mimic infection [37]. Positive cerebrospinal fluid (CSF) Gram stain and 
culture represent the gold standard for the diagnosis of an EVD-related infection [12, 34]. 
However, Gram stains often are negative even in culture-positive CSF [23] and CSF cultures 
take several days until bacterial growth can safely be excluded and do not allow early 
diagnosis of infection. 
The aim of the study at hand was to assess changes of clinical and laboratory parameters 
potentially indicating an EVD-related infection in patients suffering from SAH, ICH or TBI. 
Using subsequent positive CSF culture or Gram stain as an indicator for the occurrence of 
EVD-related infection, our study aims to evaluate changes in clinical and laboratory 
parameters during the time from EVD insertion to occurrence of possible sterile 
inflammation in the CSF space and subsequently to the time of proven EVD-related infection. 
Additionally, the diagnostic accuracy of clinical and laboratory parameters for the prediction 
of EVD-related infection was to be established.  
 
Materials and Methods: 
Study design: Retrospective observational study in two tertiary center critical care units. 
Patients: We reviewed all available medical records of all adult patients older than 16 years 
of age in whom an EVD was inserted over a period of five years at the University Hospital 
5 
 
Berne, Switzerland (center 1) and over 7 years at the Royal North Shore Hospital of Sydney, 
Australia (center 2). All neurosurgical procedure protocols during the study period were 
screened for insertion of an EVD. Patient records were matched with the microbiologic 
database of all cultured microorganism in CSF and all positive Gram stains of CSF to identify 
patients with EVD-related infections during the course of the patients hospital stay. Patients 
who presented with a primary CNS infection on admission were excluded. 
Data collection: Baseline characteristics include patient demographics, diagnosis, Glasgow 
Coma Score (GCS), Hunt & Hess [13] and Fisher [8] grading systems for SAH and ICH score 
[10] for intra-cerebral hemorrhage at ICU admission, duration of ICU and hospital stay, 
duration of EVD in place, survival at hospital discharge, Glasgow Outcome Score and 
modified Rankin Score. Clinical data included the following parameters: clinical signs of a 
systemic inflammatory response syndrome (SIRS) (temperature >38.3°C or <36°C, heart rate 
>90 beats/min, respiratory rate >20 breaths/min or PaCO2 <32 mmHg) and of CNS infection 
(nuchal rigidity, headache and changes in mental status). Signs of CNS infection were rated 
as absent if ongoing sedation did not allow for conclusive assessment. Surveillance CSF 
samples were routinely collected and blood tests performed on a daily or alternate-day basis 
in both institutions in patients with EVDs as a part of standard clinical management. The 
following parameters were extracted from the laboratory data base: red blood (RBC) count, 
blood WBC count, serum CRP level, CSF RBC count, CSF WBC count, CSF Gram stain and CSF 
culture and results of cultures of any removed EVD. All available clinical and laboratory 
parameters, starting from the day of EVD insertion until day 3 after the occurrence of EVD-
related infection, were collected and included in the study database for analysis.  
Definition of EVD-related infection: According to the NHSN/CDC definition of healthcare-
associated meningitis [12, 35], an EVD-related infection was defined as a positive CSF culture 
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or identification of bacteria on Gram stain at least 24h after placement of an EVD with 
clinical signs of infection. Coagulase negative staphylococci (CoaNS) were considered to be 
contamination if further clinical or biochemical abnormalities were absent. 
Evaluated potential predictors of EVD related infection: Evaluated potential predictors 
consisted of CSF and blood laboratory results and clinical signs of central nervous system 
infection: blood WBC count, percentage of blood WBC band forms, serum CRP levels, CSF 
cell count, CSF RBC/WBC ratio, CSF cell index, presence of positive SIRS criteria and  clinical 
sings of CNS infection. A positive cell count was defined as a CSF WBC/RBC ratio >0.01. Cell 
Index was calculated as the ratio of leukocytes to erythrocytes in CSF divided by leukocytes 
to erythrocytes in peripheral blood, according to Beer et al.[2] Clinical and laboratory 
parameters of three different time points during the period of EVD placement were included 
for further analysis. Firstly, at the time of EVD insertion (TEVD) – representing a state of 
absence of EVD-related infection and sterile inflammation; secondly 48h before occurrence 
of EVD-related infection (T-2d) – representing a state of absence of EVD related infection but 
possible presence of sterile inflammation caused by the presence of blood in the CSF space; 
and lastly, at the time of positive CSF culture (Tinf).  
Statistical Analysis: Data is presented as mean (standard deviation) for parametric and 
median (quartiles) for non-parametric data. Normal distribution was established using 
D'Agostino & Pearson omnibus normality test. For comparison of categorical variables at 
different time points Chi-square test was applied. One-way repeated-measurement ANOVA 
was used to compare continuous parameters indicative of EVD infection at the different 
predefined time points. Mauchlys test was used to assess whether the data violate the 
assumption of sphericity, in which case Greenhouse-Geisser correction was applied. All 
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statistical analyses were performed using IBM SPSS Statistics 20 and GraphPad Prism Version 
6.01.  
 
Results 
We identified and reviewed the medical records of 20 patients in center 1 and 32 patients 
center 2 with positive CSF cultures and concomitant EVD insertion after searching 
microbiological databases and matching them the with the registered adult patients with an 
EVD. A total of 10 patients were excluded from the analysis because CSF infection was 
present at the time of EVD insertion or because sufficient clinical data was not available. In 3 
patients coagulase negative staphylococci were present in the CSF sample at the time of EVD 
insertion while further clinical or biochemical abnormalities were absent. These results were 
considered to be contaminants and the patients were excluded from further analysis (Figure 
1). 39 patients with EVD associated infection were included in the final analysis. Patient 
characteristics are shown in Table 1. The majority of patients had suffered from a 
subarachnoid hemorrhage (n=20). At the time of EVD placement 31 of 39 patients were 
mechanically ventilated and 2 patients were diagnosed with non-EVD related infections, 
whereas at the time of diagnosis of EVD infection 20 of 39 patients were mechanically 
ventilated and in 14 patients non-EVD infections were diagnosed. In 38 patients, cultures of 
CSF were positive for bacterial growth; in one patient, bacteria were identified on CSF Gram 
stain, whereas the CSF culture remained negative. In sixteen patients, Gram stain was 
negative, despite positive cultures and in five patients Gram stain had not been performed. 
A total of twelve different bacteria were cultured and four cultures grew two different 
species of bacteria. Compared to patients in which CSF cultures grew one organism or 
patients in which one class of bacteria were identified on CSF Gram stain patients in which 
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cultures grew two organisms did not significantly differ regarding survival (p=1.0) or length 
of stay in ICU (p=0.292) or in hospital (p=0.08). In 13 patients, CSF samples were positive for 
coagulase negative staphylococcus and were associated with at least one clinical and 
biochemical sign of inflammation.  
At the time of infection occurrence, a significantly higher incidence of abnormal 
temperature, increased respiratory rate and a slightly but significantly higher incidence of 
decreased mental state were observed. However, at each time point a substantial 
proportion of patients received sedating drugs and therefore the occurrence of headache, 
nuchal rigidity and a decrease in mental status were not reliably determinable (Table 2). The 
assessed blood parameters blood WBC count, percentage of WBC band forms and levels of 
CRP did not significantly differ between the assessment time points. CSF analysis revealed 11 
of 39 patients with normal CSF cell counts (less than 4 cells M/l) and 17 of 39 patients with 
normal ratio of CSF WBC/RBC (< 0.01) on the day of positive CSF culture. It was only in 16 
cases that we observed increasing CSF pleocytosis. In 15 cases an increase in CSF WBC/RBC 
ratio and in 13 cases an increase in cell index was documented. The assessed CSF parameters 
featured a high inter-individual variability during the time period of EVD placement (Figure 
2a and b). The differences in CSF parameters at the different assessment time points did not 
reach statistical significance (Table 3).  
 
Discussion 
In our retrospective analysis we identified 39 patients with culture proven EVD related 
infections in a period of five years in two university hospitals. Our results indicate that none 
of the commonly used blood and CSF parameters of EVD-related infection significantly 
differed between the three analyzed time points - the time of EVD insertion, 48h before 
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occurrence of EVD-related infection, representing a state of absence of EVD related infection 
but possible presence of sterile inflammation and at the time of culture-proven CSF 
infection. At the time of EVD infection, a significantly higher incidence of abnormal 
temperature increased respiratory rate and decreased mental state was noted.  
Our study adds information about the development over time of cell counts and indices in 
CSF in a substantial cohort of patients with culture-proven EVD-related infection. We can 
show that in a large proportion of patients, CSF cell counts as wells as indices remain 
unchanged despite clinically suspected and culture proven EVD-related infection. The 
incidence of EVD related infections of 8% in our cohort and spectrum of bacterial pathogens 
cultured is consistent with earlier observations [20, 34, 36]. The study limitations mainly 
consist of the retrospective nature of the data collection and the lack of controls with similar 
baseline characteristics without infection.  
Timely diagnosis and appropriate treatment is of importance to improve the outcome of 
patients with EVD-related infections. Positive CSF cultures, along with clinical signs and 
suspicion of an infection, are considered to allow the diagnosis of EVD-related infection with 
high specificity [12]. But CSF culture results are only available with significant delay and their 
sensitivity might be impaired by concomitant antibiotic treatment. Many clinicians therefore 
rely on readily available parameters based on CSF white and red cell count when suspecting 
EVD-related infection [34]. However, in the context of SAH, ICH or TBI, the presence of blood 
in the CSF might represent a major confounder for CSF blood cell counts. Although CSF-WBC 
is routinely used to diagnose EVD-related infections, there is insufficient data to support this 
approach [25]. The CSF cell index has been introduced to account for dilution effect of CSF 
hemorrhage on the increase of CSF-WBC. The CSF cell index has shown promising results for 
the diagnosis of EVD-related infection in a prospective study with 13 patients with EVD [24]. 
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The sample size of this cohort was small and patients had a very high EVD infection rate of 
>50%. To date, only sensitivity and specificity of few single diagnostic parameters have been 
reported in the literature [17, 22]. Studies comparing changes of CSF parameters over time 
in the context of sterile inflammation due to the intra-ventricular presence of blood versus 
changes caused by EVD-related infections are scarce [29]. This information might be 
important to enable the correct interpretation of CSF results.  
Our data suggests that commonly used clinical and laboratory parameters including those 
based on CSF blood cell counts are not sufficiently sensitive and specific to be the basis for 
diagnosis and treatment decisions. Recent studies suggest a role for different cytokines and 
biomarkers measured in CSF in the diagnosis of EVD-related infection [9, 18]. However, 
before being implemented in the clinical routine these findings have to be confirmed in 
larger studies.  
We conclude that routine analysis of CSF samples to screen patients for EVD-related 
infection does not seem to be justified. In our cohort analysis of CSF samples in patients with 
EVD-related infection CSF parameter were not indicative of infection. Therefore, even in the 
context of a high suspicion of EVD infection, CSF analysis might not offer reliable additional 
information to decide if antibiotic treatment should be started. In our institutions, we start 
empiric antibiotic treatment for EVD infection based on an individual assessment of patient 
characteristics and clinical and laboratory findings indicative for EVD and non-EVD related 
infection. If CSF cultures remain negative, antibiotic treatment is discontinued. In future, 
larger prospective cohort studies of patients with EVD should be performed to further 
investigate the accuracy of diagnostic markers of EVD-related infections. 
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Figure legends 
Fig. 1: Study flow chart 
In center 1 EVD insertions in a total of 323 patients were included in the surgical data base 
while concomitantly 600 positive CSF cultures and/or CSF Gram stains were registered 
during the study period. In center 2 a total of 51 positive CSF cultures and/or Gram stains 
were identified in a registry containing all neurosurgical patients and respective 
microbiological data. After exclusion of patients with CSF drainage by other means than EVD, 
patients in whom CNS infection was present at the time of EVD insertion and patients with 
insufficient data documentation, a total of 39 patients were included for further analysis.  
 
Fig. 2a: CSF WBC stratified by days before and after occurrence of EVD infection 
The CSF white blood cell count of patients stratified in days before and after occurrence of 
EVD-related infection feature a very high inter-individual variability.  
 
Fig. 2b: CSF Cell Index stratified by days before and after occurrence of EVD infection 
The CSF cell index of patients stratified in days before and after occurrence of EVD-related 
infection feature a very high inter-individual variability.  
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Tables 
Table 1: Patient characteristics 
Parameter n 
Gender (male/female) 17/22 
Diagnosis 
 
  SAH 20 
  TBI 9 
  Tumor 3 
  AVM 2 
  ICH 5 
Neurological findings at the 
time of EVD insertion  
  GCS 13–15 14 
  GSS 9-12 5 
  GCS < 8 18 
  Hunt and Hess (median) 3 
  Fisher (median) 4 
ICU Length of stay (days) 16.6±11.9 
Survival (yes/no) 32/7 
EVD days before infection (days) 9.7 ±6.6 
Cultured organism 
 
  coagulase negative staphylococci 13 
  enterococcus faecalis 4 
  enterobacter sp. 2 
  staphylococcus aureus 4 
  staphylococcus haemolyticus 1 
  klebsiella pneumoniae 2 
  escherichia coli 1 
  seratia marcescens 2 
  acinetobacter spp 7 
  pseudomonas aeruginosa 3 
  sphingomonas paucimobilis 1 
  Bacillus 1 
Gram stain 
 
  gram negative rods 7 
  gram positive cocci 8 
  gram negative cocci 2 
  gram negative and positive rods 1 
  negative 16 
  not available 5 
AVM, arteriovenous malformation; EVD, external ventricular drainage; 
GCS, Glasgow Coma Scale; ICH, intracerebral hemorrhage; ICU, 
intensive care unit; SAH, subarachnoid hemorrhage; TBI, traumatic 
brain injury 
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Table 2: Frequencies of occurrence of clinical signs of EVD related infection at different time 
points 
 
TEVD T-2d Tinf p 
Temperature 
>38.3 or <36º 
7 (18%) 14 (36%) 19 (49%) 0.016 
Heart rate >90/min 8 (21%) 13 (33%) 15 (38%) 0.209 
Respiratory rate 
>20/min 
2 (5%) 9 (23%) 12 (31%) 0.014 
Nuchal rigidity 1 (3%) 2 (5%) 1 (3%) 0.772 
Decrease mental state 1 (3%) 5 (13%) 9 (23%) 0.041 
Headache 2 (5%) 4(10%) 7 (18%) 0.193 
Use of sedative drugs 17 (44%) 15 (38%) 19 (49%) 0.659 
EVD, external ventricular drainage; TEVD, time point of EVD insertion; T-2d, time point 2 days before occurrence of EVD infection, Tinf, 
time point of EVD infection  
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Table 3: Comparison of blood and CSF parameters indicative of EVD related infection at 
different time points 
 TEVD T-2d Tinf F-ratio p 
Blood WBC  
13.0 [10.6 – 
17.6] 
12.3 [10.0 – 
14.9] 
15.1 [10.3 – 
17.9] 
3.46 0.057 
Blood % band 
forms 
10 [9 – 16] 10 [6 – 11] 10 [7 – 14] 3.41 0.064 
Serum CRP 29 [6 – 74] 15 [1 – 39] 20 [6 – 57] 0.55 0.529 
CSF WBC 
count 
18 [2 – 258] 22 [5 – 92] 55 [2 – 1142] 3.13 0.053 
CSF WBC/RBC 
ratio 
0.0035 [0.0011 
– 0.017] 
0.0043 [0.0014 
– 0.035] 
0.0165 [0.0016 
– 0.1107] 
9.84 0.132 
CSF cell index 
0.0012 [0.0003 
– 0.0043] 
0.0012 [0.0003 
– 0.0061] 
0.0031 [0.0002 
– 0.0316] 
3.30 0.087 
CRP, C-reactive protein; CSF, cerebrospinal fluid; EVD, external ventricular drainage; p, significance value; TEVD, time point of EVD 
insertion; T-2d, time point 2 days before occurrence of EVD infection, Tinf, time point of EVD infection; WBC, white blood cell count 
 
 
 
